Reduce My Risk®
Putting patients on the path to prevention.
The development of practical tools that enable healthcare providers to identify which individuals are at high risk for cardiometabolic diseases is an enormous milestone. However, in a concerted effort to help fulfill the promise of diabetes prevention, Tethys is going beyond blood tests to also provide physicians with support services to help their patients reduce their risk for developing these devastating illnesses.
Targeting diabetes.
The company’s first service offering, the Reduce My Risk® Diabetes Prevention Initiative (RMR), is an educational program targeted to individuals who are at high risk for type 2 diabetes but have not yet developed the disease. The RMR curriculum is based in part on the methods used in the Diabetes Prevention Program (DPP), a landmark clinical study that documented the efficacy of lifestyle changes in reducing diabetes risk.12
The Reduce My Risk Initiative takes a comprehensive “mind and body” approach, teaching patients to make smart food choices and to find physical activities that will inspire them to stay active, while also showing them how to overcome the emotional issues and negative thinking that can prevent them from reaching their goals.
A patient-friendly platform for disease education.
As the Tethys product line expands to include products to determine risk for first-time heart attack, osteoporotic fracture and other cardiometabolic diseases, the Reduce My Risk® platform will be utilized to create educational and motivational programs specific to each disease state.
